Calliditas Therapeutics AB Sponsored ADR Current Ratio 2020-2024 | CALT
Calliditas Therapeutics AB Sponsored ADR current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-06-30 | $0.11B | $0.04B | 2.69 |
| 2024-03-31 | $0.11B | $0.04B | 2.69 |
| 2023-12-31 | $0.12B | $0.04B | 3.13 |
| 2023-09-30 | $0.10B | $0.03B | 3.01 |
| 2023-06-30 | $0.11B | $0.03B | 3.84 |
| 2023-03-31 | $0.12B | $0.03B | 3.93 |
| 2022-12-31 | $0.14B | $0.03B | 4.34 |
| 2022-09-30 | $0.09B | $0.02B | 4.42 |
| 2022-06-30 | $0.10B | $0.02B | 5.32 |
| 2022-03-31 | $0.10B | $0.02B | 5.37 |
| 2021-12-31 | $0.12B | $0.02B | 7.48 |
| 2021-09-30 | $0.15B | $0.02B | 8.97 |
| 2021-06-30 | $0.09B | $0.02B | 6.04 |
| 2021-03-31 | $0.11B | $0.01B | 7.75 |
| 2020-12-31 | $0.11B | $0.01B | 9.82 |
| 2020-09-30 | $0.16B | $0.01B | 23.46 |
| 2020-06-30 | $0.15B | $0.01B | 24.59 |
| 2020-03-31 | $0.08B | $0.01B | 13.31 |
| 2019-12-31 | $0.09B | $0.01B | 15.39 |
| 2019-09-30 | $0.09B | $0.00B | 30.67 |
| 2019-06-30 | $0.07B | $0.01B | 16.36 |
| 2019-03-31 | $0.07B | $0.00B | 20.43 |
